These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7921851)

  • 1. Recent developments in research of HIV infection--a "state of art" (a review).
    Füst G
    Acta Microbiol Immunol Hung; 1994; 41(1):5-21. PubMed ID: 7921851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic indices for the course of HIV infection].
    Hess G
    Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
    Scriba TJ; Zhang HT; Brown HL; Oxenius A; Tamm N; Fidler S; Fox J; Weber JN; Klenerman P; Day CL; Lucas M; Phillips RE
    J Clin Invest; 2005 Feb; 115(2):443-50. PubMed ID: 15668739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune control of HIV-1 after early treatment of acute infection.
    Rosenberg ES; Altfeld M; Poon SH; Phillips MN; Wilkes BM; Eldridge RL; Robbins GK; D'Aquila RT; Goulder PJ; Walker BD
    Nature; 2000 Sep; 407(6803):523-6. PubMed ID: 11029005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV: Bad news for stop--start therapy?
    McMichael AJ; Rowland-Jones SL
    Nature; 2002 Nov; 420(6914):371, 373. PubMed ID: 12459769
    [No Abstract]   [Full Text] [Related]  

  • 6. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
    Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
    Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy leads to a significant but delayed increase of CD45RA+ T-helper cells.
    Degen O; Stellbrink HJ; Lauer J; van Lunzen J
    AIDS; 1998 Sep; 12(13):1715-6. PubMed ID: 9764793
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the body control HIV infection without drugs?
    Check E
    Newsweek; 2000 Oct; 136(15):59. PubMed ID: 11184537
    [No Abstract]   [Full Text] [Related]  

  • 10. SPV-30 shows encouraging results.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186-7. PubMed ID: 11361631
    [No Abstract]   [Full Text] [Related]  

  • 11. Expansion of CD60 helper lymphocytes detected in peripheral lymphocytes of HIV-1 infected individuals is not paralleled in lymph nodes.
    Bogner JR; Gruber R; Steckmeier B; Goebel F; Rieber EP
    Eur J Med Res; 2000 Apr; 5(4):150-6. PubMed ID: 10799349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.
    Fogelman I; Davey V; Ochs HD; Elashoff M; Feinberg MB; Mican J; Siegel JP; Sneller M; Lane HC
    J Infect Dis; 2000 Aug; 182(2):435-41. PubMed ID: 10915073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of T cell immune responses in HIV-infected children from Uganda.
    Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
    J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.
    Haslett PA; Nixon DF; Shen Z; Larsson M; Cox WI; Manandhar R; Donahoe SM; Kaplan G
    J Infect Dis; 2000 Apr; 181(4):1264-72. PubMed ID: 10751137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dangerous T-cell amnesia.
    Gorochov G
    Nat Med; 1999 May; 5(5):483-4. PubMed ID: 10229218
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
    Lu W; Arraes LC; Ferreira WT; Andrieu JM
    Nat Med; 2004 Dec; 10(12):1359-65. PubMed ID: 15568033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.